NewsRoom Articles - Page 114 of 207

ThursdayMar 03, 2022 9:30 am

Researchers Uncover Why Naked Mole Rats Live Long

A new study has found that naked mole rats demonstrate exceptional resistance to cancer and aging. Naked mole rats have long interested researchers involved in cancer research and aging research. Recently, researchers from the Kumamoto University in Japan succeeded in isolating stem cells from the brains of these rodents. In their report, the researchers explained how these cells helped maintain body homeostasis, which is important in cancer resistance and aging. Cancer and aging is caused by the depletion and dysfunction of tissue-specific stem cells, which are cells that differentiate to form specialized cells. These cells were found throughout the bodies…

ThursdayMar 03, 2022 9:00 am

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Granted U.S. Patent for Deuterated DMT

Company announced the first officially issued patent Patent provides strong protection for Cybin’s growing IP portfolio of psychedelic-based compounds CYB004 has demonstrated potential efficacy at lower doses while increasing duration of drug effect that may alleviate common negative experiences In a milestone moment for psychedelic therapeutics company Cybin (NEO: CYBN) (NYSE American: CYBN), the company has announced its first official issued patent. The U.S. Patent and Trademark Office (“USPTO”) has granted U.S. patent 11,242,318 to Cybin’s proprietary CYB004, the company’s lead investigational proprietary DMT compound. “From the outset, Cybin has focused on creating differentiated compounds that harness the potential efficacy of…

WednesdayMar 02, 2022 9:30 am

Researchers to Study Why Music, Art Therapy Benefits Mental Health Patients

The National Endowment for the Arts is sponsoring an arts therapy initiative known as Creative Forces in partnership with the Department of Veterans Affairs and Department of Defense. Art therapies are increasingly being used to treat various brain conditions, including Alzheimer’s, Parkinson’s disease, depression and post-traumatic stress disorder. However, most of these therapies, ranging from poetry to music to visual arts, haven’t undergone exhaustive scientific testing. Brain researchers and artists have started an initiative called the NeuroArts Blueprint to conduct research into this. The initiative is the result of collaboration between the Aspen Institute’s Health, Medicine and Society Program, and…

WednesdayMar 02, 2022 9:15 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) and BayMedica Rare Cannabinoids to Enter Market Q1 2022; Leveraging on Fast-Growing Global Health and Wellness Market

Over 140 rare cannabinoids exist in the cannabis plant – some with the potential to have more therapeutic benefits than those cannabinoids found prominently in the plant InMed and subsidiary BayMedica plan to release several rare cannabinoid products in the first half of 2022 Combination of complementary InMed and BayMedica business models key to increasing shareholders’ value In 2020, the global health and wellness market reached $4.436 trillion and is expected to grow at a CAGR of 5.5% from 2021 to 2030, resulting in an estimated value of $7.7 trillion by the end of the forecasted period (https://ibn.fm/BjCNi). The primary…

WednesdayMar 02, 2022 9:00 am

Nemaura Medical Inc.’s (NASDAQ: NMRD) sugarBEAT(R) Wearable CGM Device Targets Billion-Dollar Global Diabetes Market

Global diabetes-related healthcare expenses are estimated at $966 billion in 2021 A recent report reveals 537 million adults currently live with diabetes, projected to rise to 643 million by 2030 and 783 million by 2045 Glucose intake is an important factor in diabetes management, prevention and reversal NMRD’s sugarBEAT(R) wearable is a non-invasive, flexible CGM device helping diabetes and prediabetes patients monitor glucose levels NMRD’s MiBoKo metabolic health program recently launched, provides AI-powered insights based on glucose readings Diabetes is a primary driver of chronic disease costing the healthcare services sector more than $966 billion in 2021. Nemaura Medical (NASDAQ:…

TuesdayMar 01, 2022 9:30 am

New Study Investigates Negative Effects of Being Obsessively Passionate About Your Job

New research has explained why being obsessively passionate about one’s job may have maladaptive and negative outcomes for a person. University of Manitoba professor Benjamin Schellenberg, the lead author of the study, stated that obsessively passionate individuals reported lower levels of psychological well-being and also experienced more stress, anxiety and negative emotions. The researchers’ objective was to find out why obsessive passion was common in the workplace, despite these negative consequences. For their study, the researchers carried out a series of studies that evaluated lay beliefs about passion from a number of perspectives. Every participant in each study was instructed…

MondayFeb 28, 2022 9:30 am

More Children Are Being Diagnosed with Diabetes after Pandemic

Type 1 diabetes is also referred to as insulin-dependent diabetes or juvenile diabetes. It’s a chronic condition in which the pancreas produces no insulin or little insulin. Insulin is a hormone required in the body that allows glucose (sugar) to enter cells in order to produce energy. Since the coronavirus pandemic began, doctors have observed a significant increase in diagnoses for type 1 diabetes, particularly in children. Various factors may contribute to the development of type 1 diabetes, the most common being genetics and exposure to some viruses, as well as other environmental factors. While this chronic condition usually appears…

MondayFeb 28, 2022 9:15 am

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Makes Exciting Drug Discovery for the Treatment of Mental health and Addiction Disorders – MYCO-005

Mydecine announced the inclusion of a patent-pending novel molecule in its family of psilocin analogs, MYCO-005 This molecule features potentially heart-safe microdose-enabling properties, addressing the delivery and stability concerns associated with the first-generation compounds Mydecine’s patent-pending dermal route to administration also offers more control over the drug while possibly eliminating undesirable properties such as nausea The company is excited about this finding, terming it one of the many exciting drug discoveries it looks to share in the near term Microdosing, the act of consuming a minimal dose of a psychedelic to benefit from what it offers without going through a…

FridayFeb 25, 2022 9:30 am

Experimental Herpes Virus May Help Fight Fatal Brain Cancer

A new study has found that an experimental herpes simplex virus may help fight glioblastoma brain tumors. Glioblastoma brain tumors have an average survival period of 12 to 15 months from when one individual receives a diagnosis and four to six months after they recur. Dr. James Markert, the study’s senior researcher, stated that despite almost six decades of research and advances in radiation, chemotherapy and surgery, not much has changed with regard to survival. Markert, who is chairman of neurosurgery at the Heersink School of Medicine, University of Alabama, added that only 5% to 10% of patients diagnosed with…

FridayFeb 25, 2022 9:15 am

Nemaura Medical Inc. (NASDAQ: NMRD) Publishes 3QFY2022 Results; Company Reports its Inaugural Quarterly Revenues

Nemaura Medical has recently reported its 3QFY2022 (4QCY2021) results, with the company recognizing its inaugural revenues of $183,628 over the quarter The company also announced that it held $23 million in cash reserves as of the end of the quarter, which should amply cover its cash requirements over the coming months Nemaura Medical seized upon the opportunity to update investors on their ongoing operational highlights, which include the appointment of Dr. Arash Ghadar as COO, the formal launch of their Miboko product line Finally, the company also announced a new investment received from Tiger Partners Trading LLC, an investment advisor…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Researchers Uncover Why Naked Mole Rats Live Long

Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) Granted U.S. Patent for Deuterated DMT

Researchers to Study Why Music, Art Therapy Benefits Mental Health Patients

InMed Pharmaceuticals Inc. (NASDAQ: INM) and BayMedica Rare Cannabinoids to Enter Market Q1 2022; Leveraging on Fast-Growing Global Health and Wellness Market

Nemaura Medical Inc.’s (NASDAQ: NMRD) sugarBEAT(R) Wearable CGM Device Targets Billion-Dollar Global Diabetes Market

New Study Investigates Negative Effects of Being Obsessively Passionate About Your Job

More Children Are Being Diagnosed with Diabetes after Pandemic

Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) Makes Exciting Drug Discovery for the Treatment of Mental health and Addiction Disorders – MYCO-005

Experimental Herpes Virus May Help Fight Fatal Brain Cancer

Nemaura Medical Inc. (NASDAQ: NMRD) Publishes 3QFY2022 Results; Company Reports its Inaugural Quarterly Revenues

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search